Apollo Therapeutics
Cambridge, GB · 4 known investors
Find your way into Apollo Therapeutics
726 people in our graph share verified history with the Apollo Therapeutics team — schools, employers, funds. One of them is your warm intro.
Bill Pescatellounlockedknows Sanjay Aggarwal · together at The University of Chicago Booth School of Business (overlapped)
×5knows the team · via University of Cambridge
knows the team · via The University of Chicago Booth School of Business
×3knows the team · via University of York
×2knows the team · via Amgen
A portfolio biopharmaceutical company translating basic medical research breakthroughs from leading universities into novel therapeutic medicines. The company develops a diversified pipeline of drug candidates through partnerships with top research institutions and selective in-licensing of clinical-stage programs.
Founders & leadership
RB
Richard ButtinChief Scientific OfficerRichard Butt is Chief Scientific Officer of Apollo Therapeutics, a biopharmaceutical company developing drug candidates through partnerships with leading academic research institutions.
SA
Sanjay AggarwalinChief Medical OfficerSanjay Aggarwal is a pharmaceutical physician with international clinical development experience across oncology, hematology, respiratory, metabolic, and infectious diseases, holding qualifications in internal medicine (MRCP UK) and an MBA.
Investors · 4
Also in the syndicate · 1
M&G plc
Funding
SEC filings, press & company announcements$226.5M disclosed across 1 round · 2023
- $226.5MSeries CSep 2023 · 3 sources
Patient Square Capital (lead), M&G plc, Rock Springs Capital
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Apollo Therapeutics do?
- A portfolio biopharmaceutical company translating basic medical research breakthroughs from leading universities into novel therapeutic medicines. The company develops a diversified pipeline of drug candidates through partnerships with top research institutions and selective in-licensing of clinical-stage programs.
- Who are Apollo Therapeutics's investors?
- Apollo Therapeutics's investors include Patient Square Capital, Rock Springs Capital, AlbionVC.
- How much funding has Apollo Therapeutics raised?
- Apollo Therapeutics has disclosed $226.5M raised across 1 round.
- Where is Apollo Therapeutics headquartered?
- Apollo Therapeutics is headquartered in Cambridge, GB.